Pediatric adrenal incidentaloma as a rare and difficult to diagnose finding - review
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.019Keywords
Pediatric adrenal incidentaloma, neuroblastoma, pheochromocytoma, adrenocortical carcinomaAbstract
Adrenal incidentaloma (AI) is an asymptomatic mass localized in the adrenal gland, usually detected during diagnostic imaging performed due to other health issues than the suspected adrenal disease. It occurs in 2% of adults and 0,2% of children. Pediatric AI may cause many difficulties in the diagnostic processes. Neuroblastoma is one of the most common malignant tumors in children. Usually, it is localized in the medulla of the adrenal gland. Many patients do not have any symptoms, but some may present with fever, weariness, weight loss, pain, enlarging mass, etc. The majority of cases are high- risk and the survival rate is less than 50%. The diagnostic protocol consists of laboratory tests and radiological imagining. Treatment depends on the risk group that the patient is assigned to. Pheochromocytoma is a rare catecholamine-secreting tumor in children originating in the adrenal medulla. Most pediatric patients present with sustained hypertension. 60% of pheochromocytoma cases are sporadic. The surgical removal of the tumor through adrenalectomy is a standard procedure. To the group of pediatric adrenocortical tumors (ACT), benign adrenocortical adenoma (ACA) and malignant adrenocortical carcinoma (ACC) are included. ACA is found in only 20% of cases of ACT. Most of the patients present with signs of virilization, Cushing Syndrome, or both. The 5-years survival rate of ACC in the pediatric population is 46-55%. An adrenal incidentaloma is an unpredictable and possibly dangerous disorder in the pediatric population. Due to the rarity of the finding and their variety, there is not much data and clear recommendations about AI management. Doctors need to know about the prevalence of different types of adrenal tumors in the pediatric population based on age.
References
McRae JJLH, Radulescu A, Khan FA. Pediatric adrenal incidentaloma. Journal of Pediatric Surgery Case Reports. 2020 Sep;60:101573. DOI: 10.1016/j.epsc.2020.101573
Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, et al. Adrenal Incidentaloma. Endocrine Reviews. 2020 Dec 1;41(6):775–820. DOI: 10.1210/endrev/bnaa008
Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016 Aug;175(2):G1–34. DOI: 10.1530/EJE-16-0467
Vurallı D, Kandemir N, Clark G, Orhan D, Alikaşifoğlu A, Gönç N, et al. A pheochromocytoma case diagnosed as adrenal incidentaloma. The Turkish Journal of Pediatrics. 2017;59(2):200. DOI: 10.24953/turkjped.2017.02.015
Gupta N, Rivera M, Novotny P, Rodriguez V, Bancos I, Lteif A. Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017. Hormone Research in Paediatrics. 2018 Sep 1;90(1):8–18. DOI: 10.1159/000488855
Dutt M, Jialal I. Physiology, Adrenal Gland [Internet]. StatPearls. StatPearls Publishing; 2019 [cited 2022 Jul 25]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30725945
Qiu B, Matthay KK. Advancing therapy for neuroblastoma. Vol. 19, Nature Reviews Clinical Oncology. Nature Research; 2022. p. 515–33. DOI: 10.1038/s41571-022-00643-z
Li F, Zhang W, Hu H, Zhang Y, Li J, Huang D. Factors of Recurrence After Complete Response in Children with Neuroblastoma: A 16-Year Retrospective Study of 179 Cases. Cancer Management and Research. 2022;14:107–22. DOI: 10.2147/CMAR.S343648
Johnsen JI, Dyberg C, Wickström M. Neuroblastoma—A Neural Crest Derived Embryonal Malignancy. Frontiers in Molecular Neuroscience. 2019 Jan 29;12. DOI: 10.3389/fnmol.2019.00009
Maris JM. Recent Advances in Neuroblastoma. New England Journal of Medicine. 2010 Jun 10;362(23):2202–11. DOI: 10.1056/NEJMra0804577
Molecular Basis and Clinical Features of Neuroblastoma. JMA Journal. 2021;4(4). DOI: 10.31662/jmaj.2021-0077
Colon NC, Chung DH. Neuroblastoma. Advances in Pediatrics. 2011;58(1):297–311. DOI: 10.1016/j.yapd.2011.03.011
Samim A, Tytgat GAM, Bleeker G, Wenker STM, Chatalic KLS, Poot AJ, et al. Nuclear medicine imaging in neuroblastoma: Current status and new developments. Vol. 11, Journal of Personalized Medicine. MDPI AG; 2021. DOI: 10.3390/jpm11040270
Olecki E, Grant CN. MIBG in neuroblastoma diagnosis and treatment. Seminars in Pediatric Surgery. 2019 Dec 1;28(6):150859. DOI: 10.1016/j.sempedsurg.2019.150859
van Arendonk K, Chung D. Neuroblastoma: Tumor Biology and Its Implications for Staging and Treatment. Children. 2019 Jan 17;6(1):12. DOI: 10.3390/children6010012
JPMA - Journal Of Pakistan Medical Association [Internet]. [cited 2022 Jul 25]. Available from: https://jpma.org.pk/article-details/8986?article_id=8986
Park H, Kim MS, Lee J, Kim JH, Jeong BC, Lee S, et al. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea. Frontiers in Endocrinology [Internet]. 2021 Jan 29 [cited 2022 Jul 25];11:1073. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2020.610746/full
Sarathi V. Characteristics of pediatric pheochromocytoma/paraganglioma. Vol. 21, Indian Journal of Endocrinology and Metabolism. Medknow Publications; 2017. p. 470–4. DOI: 10.4103/ijem.IJEM_558_16
Conzo G, Pasquali D, Colantuoni V, Circelli L, Tartaglia E, Gambardella C, et al. Current concepts of pheochromocytoma. Vol. 12, International Journal of Surgery. Elsevier Ltd; 2014. p. 469–74. DOI: 10.1016/j.ijsu.2014.04.001
Younes A, Elgendy A, Zekri W, Fadel S, Elfandy H, Romeih M, et al. Operative management and outcomes in children with pheochromocytoma. Asian Journal of Surgery. 2022 Jan 1;45(1):419–24. DOI: 10.1016/j.asjsur.2021.07.029
Cerqueira A, Seco T, Costa A, Tavares M, Cotter J. Pheochromocytoma and Paraganglioma: A Review of Diagnosis, Management and Treatment of Rare Causes of Hypertension. Cureus. 2020 May 5;12(5). DOI: 10.7759/cureus.7969
Bholah R, Bunchman TE. Review of pediatric pheochromocytoma and paraganglioma. Vol. 5, Frontiers in Pediatrics. Frontiers Media S.A.; 2017. DOI: 10.3389/fped.2017.00155
Miele E, di Giannatale A, Crocoli A, Cozza R, Serra A, Castellano A, et al. Clinical, Genetic, and Prognostic Features of Adrenocortical Tumors in Children: A 10-Year Single-Center Experience. Frontiers in Oncology [Internet]. 2020 Oct 15 [cited 2022 Jul 25];10:1874. Available from: https://www.frontiersin.org/article/10.3389/fonc.2020.554388/full
Traynor MD, Sada A, Thompson GB, Moir CR, Bancos I, Farley DR, et al. Adrenalectomy for non-neuroblastic pathology in children. Pediatric Surgery International. 2020 Feb 5;36(2):129–35. DOI: 10.1007/s00383-019-04589-9
Michalkiewicz E, Sandrini R, Figueiredo B, Miranda ECM, Caran E, Oliveira-Filho AG, et al. Clinical and outcome characteristics of children with adrenocortical tumors: A report from the international pediatric adrenocortical tumor registry. Journal of Clinical Oncology [Internet]. 2004 Mar 1 [cited 2022 Jul 25];22(5):838–45. Available from: https://ascopubs.org/doi/10.1200/JCO.2004.08.085
Pinto EM, Zambetti GP, Rodriguez-Galindo C. Pediatric adrenocortical tumours. Best Practice & Research Clinical Endocrinology & Metabolism. 2020 May;34(3):101448. DOI: 10.1016/j.beem.2020.101448
Li S, Duan L, Wang FD, Lu L, Jin ZY. Carney complex: Two case reports and review of literature. World Journal of Clinical Cases. 2018 Nov 26;6(14):800–6. DOI: 10.12998/wjcc.v6.i14.800
Wang KH, Kupa J, Duffy KA, Kalish JM. Diagnosis and Management of Beckwith-Wiedemann Syndrome. Frontiers in Pediatrics. 2020 Jan 21;7. DOI: 10.3389/fped.2019.00562
Frebourg T, Bajalica Lagercrantz S, Oliveira C, Magenheim R, Evans DG, Hoogerbrugge N, et al. Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes. European Journal of Human Genetics. 2020 Oct 1;28(10):1379–86. DOI: 10.1038/s41431-020-0638-4
Virgone C, Roganovic J, Vorwerk P, Redlich A, Schneider DT, Janic D, et al. Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatric Blood & Cancer. 2021 Jun 26;68(S4). DOI: 10.1002/pbc.29025
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Dominika Pałac, Magdalena Ostrowska, Magdalena Grześk-Kaczyńska, Szymon Kaczyński
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 374
Number of citations: 0